HHS cancels Moderna mRNA vaccine award amid safety concerns
HEAVILY 30% 80% Wednesday, May 28, 2025, 9:22 pm
The Department of Health and Human Services abruptly cancelled funding for Moderna’s mRNA-based bird flu vaccine, citing safety concerns and insufficient testing. This sudden decision highlights the administration’s cautious stance on rapidly developed mRNA technology, leaving industry observers both baffled and amused.
Bluesky: @isaidhi.bsky.social, @cbsnews.com.web.brid.gy
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of oversight around the new mRNA vaccine technology.
The Trump administration canceled a nearly $600 million award to Moderna to develop an mRNA vaccine for bird flu in humans, the company announced Wednesday.Why it matters: It ends one of the remaining Biden-era efforts aimed at creating vaccines for pandemic preparedness. But the company said it…
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
The cancelation came as Moderna announced positive interim results from an early-stage trial of a new shot.
permalink / 4 stories from sources in 4 days ago #healthcare #safety #covid #moderna
More Top Stories...
Trump and Xi set to discuss trade negotiations soon
Sources indicate that President Trump and President Xi Jinping are expected to engage in trade talks imminently. Although no fixed date has been announced, economic advisors suggest that the two leaders are poised to address ongoing trade tensions with significant global and political implications. More...
Trump tariff strategy faces legal and political firestorm
Key officials and administration advisers double down on Trump’s tariff policy amid legal challenges and economic uncertainty. Remarks defending sharply increased steel tariffs and insisting on their permanence have sparked heated debate, with critics suggesting the move is as immovable as a stubborn trade relic. More...
Senate Tweaks Trump’s “Big Beautiful Bill” Amid Outrage
Lawmakers are re-examining Trump’s so-called “Big Beautiful Bill” after a single, controversial paragraph sparked widespread criticism for its potential sweeping spending cuts. As Senate Republicans eye modifications to salvage the legislation, critics point to the hidden snafus and political acrobatics that make the bill as baffling as it is bold. More...
US Visa Revocation Plan Sparks Political Backlash
The administration’s move to revoke visas for Chinese students has ignited intense political criticism. Analysis of the policy’s potential fallout was matched by a sharp rebuke from a prominent lawmaker, who deemed the plan “terribly misguided.” The controversy underscores rising tensions over academic freedom and international relations. More...
Detention of NY aide fuels accusations of political intimidation
Federal agents briefly detained a New York representative’s aide, prompting sharp criticism from key Democratic leaders. Accusations flew that the move was a politically motivated power play intended to intimidate opposition, leaving observers to ponder whether overreach has become the administration’s trademark. More...
Related Tags
Healthcare
FDA chief outlines COVID vaccine guidance amid controversy (12 hours ago)
Devin Harjes dies at 41 from cancer complications (13 hours ago)
DJ Daniel’s Health Setback Deepens Amid Early Triumphs (34 hours ago)
Safety
Stabbing at Salem Oregon Homeless Mission Shakes Community (1 hour ago)
Missouri House Explosion Shocks Local Community (8 hours ago)
Boulder Pearl Street Mall Terror Incident Probe (10 hours ago)
COVID
FDA chief outlines COVID vaccine guidance amid controversy (12 hours ago)
Moderna’s Next-Gen Shot Approved (40 hours ago)
CDC Revises Child COVID-19 Vaccination Guidance Amid Debate (2 days ago)
Moderna
Moderna’s Next-Gen Shot Approved (40 hours ago)
CDC Revises Child COVID-19 Vaccination Guidance Amid Debate (2 days ago)
Trump Administration Axes Moderna’s Bird Flu Vaccine Contract (3 days ago)